0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

CLINICAL USE OF TOLBUTAMIDE (ORINASE) IN OFFICE AND HOME CARE OF DIABETICS

James C. Breneman, M.D.
JAMA. 1957;164(6):627-633. doi:10.1001/jama.1957.02980060003002.
Text Size: A A A
Published online

• Tolbutamide was administered orally to 45 patients with various types of diabetes. The patients in one group, consisting of new diabetics and of old diabetics who had refused insulin, were instructed to live as they had before except to take one 0.5-Gm. tablet four times daily. A second group, consisting of patients who had used repository types of insulin, went without insulin or other medication for four days before starting the use of tolbutamide. A third group of patients who had been taking insulin reduced their insulin intake by 25% while increasing the dosage of tolbutamide by 0.5 Gm. each day until the use of insulin was stopped and the dosage of tolbutamide was 2.0 Gm. daily. Five patients proved to have the juvenile type of diabetes and showed no evidence of control by tolbutamide. Four patients who still depended on insulin responded to the tolbutamide by a significant reduction of their insulin requirements. Thirty-six patients were classified as excellent responders in that tolbutamide proved sufficient for diabetic control. All good and excellent responders were in their late 30's when their diabetes was discovered; they were generally obese, and women responded more frequently than men. Side-effects of transient, subjective nature have been reported by four patients but have not been noted in eight others after more than 11 months of tolbutamide therapy. The drug was most useful in mild, uncomplicated cases of diabetes developing after the age of 30 years in somewhat obese patients.

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Figures

Tables

References

Letters

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();